Skip to main content
. Author manuscript; available in PMC: 2016 Apr 23.
Published in final edited form as: Curr Vasc Pharmacol. 2016;14(1):116–124. doi: 10.2174/1570161113666150916094829

Fig. 1. Overview of the PAPI Study Design.

Fig. 1

After the initial screening visit, subjects underwent a seven day washout period followed by baseline aggregation measurements. All participants were then given a 300 mg loading dose of clopidogrel followed by 75 mg daily for 7 days. After their last dose of clopidogrel, platelet aggregation measurements were taken, followed by the administration of 325 mg of aspirin. Final aggregation measurements were taken 2 h post-aspirin dose.